共 22 条
[11]
CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement[J] . Han‐JingCen,Wu‐TaoZeng,Xiu‐YuLeng,MinHuang,XiaoChen,Jia‐LiLi,Zhi‐YingHuang,Hui‐ChangBi,Xue‐DingWang,Yan‐LingHe,FanHe,Rui‐NaZhou,Qi‐ShanZheng,Li‐ZiZhao.British Journal of Clinical Pharmacology . 2010 (2)
[12]
Influence of GGCX genotype on warfarin dose requirements in Chinese patients[J] . Sheng-Wen Huang,Dao-Kang Xiang,Ling Huang,Bao-Lin Chen,Bang-Quan An,Gui-Fang Li,Zhen-Yuan Luo.Thrombosis Research . 2010 (2)
[13]
ARMS test for diagnosis of CYP2C9 and VKORC1 mutation in patients with pulmonary embolism in Han Chinese
[J].
PHARMACOGENOMICS,
2010, 11 (01)
:113-119
Zhu, Jin
;
Zhang, Weijuan
;
Li, Yanyan
;
Zhang, Wei
;
Wang, Heyao
;
Zheng, Wenjie
;
Wang, Chen
.
[14]
Genetic determinants of warfarin dosing in the Han-Chinese population
[J].
PHARMACOGENOMICS,
2009, 10 (12)
:1905-1913
Lee, M. T. Michael
;
Chen, Chien-Hsiun
;
Chou, Ching-Heng
;
Lu, Liang-Suei
;
Chuang, Hui-Ping
;
Chen, Ying-Ting
;
Saleem, Amir N.
;
Wen, Ming-Shien
;
Chen, Jin-Jer
;
Wu, Jer-Yuarn
;
Chen, Yuan-Tsong
.
[15]
Impact of VKORC1 gene polymorphism on interindividual and interethnic warfarin dosage requirement— A systematic review and meta analysis[J] . Limei Yang,Weihong Ge,Feng Yu,Huaijun Zhu.Thrombosis Research . 2009 (4)
[16]
Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients[J] . Sheng-Wen Huang,Hai-Sheng Chen,Xian-Qun Wang,Ling Huang,Ding-Li Xu,Xiao-Jia Hu,Zhi-Hui Huang,Yong He,Kai-Ming Chen,Dao-Kang Xiang,Xiao-Ming Zou,Qiang Li,Li-Qin Ma,Hao-Fei Wang,Bao-Lin Chen,Liang Li,Yan-Kai Jia,Xiang-Min Xu.Pharmacogenetics and Genomics . 2009 (3)
[17]
Influence of CYP2C9 genotype on warfarin dose requirements-a systematic review and meta-analysis
[J].
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY,
2009, 65 (04)
:365-375
Lindh, Jonatan D.
;
Holm, Lennart
;
Andersson, Marine L.
;
Rane, Anders
.
[18]
Genetic factors contribute to patient-specific warfarin dose for Han Chinese[J] . Ting-Liang Wang,Hong-Lei Li,Wen-Ye Tjong,Qian-Su Chen,Guan-Sheng Wu,Hai-Tao Zhu,Zi-Shan Hou,Shu Xu,Sheng-Jun Ma,Madeline Wu,Susan Tai.Clinica Chimica Acta . 2008 (1)
[19]
Healthcare impact of personalized medicine using genetic testing: an exploratory analysis for warfarin[J] . Andrew McWilliam,Randall Lutter,Clark Nardinelli.Personalized Medicine . 2008 (3)
[20]
Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients[J] . Liyan Miao,Jian Yang,Chenrong Huang,Zhenya Shen.European Journal of Clinical Pharmacology . 2007 (12)